anmelden
SLI
2.143,87
PKT
+4,47
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.04.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.04.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.04.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 19.04.18 | Nestlé Neutral | UBS AG | |
| 19.04.18 | Novartis Neutral | UBS AG | |
| 19.04.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 19.04.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 19.04.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.04.18 | Novartis Outperform | Bernstein Research | |
| 19.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.04.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.04.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 18.04.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.04.18 | Roche Neutral | Credit Suisse Group | |
| 18.04.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 18.04.18 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 17.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.04.18 | Roche Underweight | Morgan Stanley | |
| 17.04.18 | Nestlé Underperform | BNP PARIBAS | |
| 17.04.18 | Roche Hold | Deutsche Bank AG | |
| 17.04.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 17.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 17.04.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.04.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 16.04.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 16.04.18 | Roche Hold | Deutsche Bank AG | |
| 16.04.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 13.04.18 | Roche buy | Jefferies & Company Inc. | |
| 13.04.18 | Novartis buy | Jefferies & Company Inc. | |
| 13.04.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 13.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 12.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 12.04.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.18 | Novartis Hold | Deutsche Bank AG | |
| 12.04.18 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 11.04.18 | Givaudan Hold | Société Générale Group S.A. (SG) |